Healthtech Startups

Arya provides AI-powered digital agents that automate front-office and workforce management tasks for healthcare providers, including applicant engagement, scheduling, payroll, compliance, and staff engagement. The platform is designed for healthcare operators to reduce administrative burden and improve clinical workforce utilization.

1 investor

Aryv operates a non-emergency medical transportation (NEMT) service, connecting drivers with passengers who need rides to and from medical appointments. It uses a driver pay model and works with brokers such as MTM, with operations in states including Wisconsin and Florida.

1 investor

Asahi Surgical Robotics develops and manufactures surgical support robotic systems for medical facilities. The company focuses on improving quality of life for patients, families, and healthcare professionals through medical device innovation.

1 investor

Ascelia Pharma is a biotech company developing and commercializing drugs for rare, orphan oncology-related conditions with unmet medical needs. Its clinical-stage pipeline includes Orviglance, an oral MRI contrast agent for detecting liver lesions, and Oncoral, an oral chemotherapy tablet for gastric cancer.

1 investor

Ascendia Pharmaceutical Solutions is a contract development and manufacturing organization (CDMO) that provides formulation, nanotechnology, and manufacturing services for pharmaceutical and biological companies from pre-formulation through commercialization. The company specializes in solving drug development challenges for small molecules, biologics, and gene delivery applications.

1 investor

Ascertain provides an agentic AI platform that automates healthcare administrative work such as prior authorizations, referrals, eligibility checks, and care coordination by integrating with existing systems and embedding human review. It serves specialty practices, management service organizations, health systems, and health plans to reduce administrative burden across revenue cycle and care management.

1 investor

Ascidian Therapeutics is a biotechnology company developing RNA-based therapeutics, with a clinical focus that includes ophthalmology and inherited retinal diseases.

1 investor

Asclepii makes Poseidon, an FDA-cleared nanosilver hydrogel wound dressing that maintains a moist wound environment and blocks microbes for topical wound management. It is used by clinicians such as podiatrists and nurses for chronic and everyday wound care.

1 investor

Asclepius MedTech develops remote patient monitoring systems for pre- and post-surgical care. The company is advised by medical professionals including orthopaedic surgeons.

1 investor

ASEM Technology develops a non-invasive measurement platform based on the ASEM method (acousto-electromagnetic method), which uses ultrasound to detect electric and magnetic polarization inside materials and visualize qualitative degradation or alteration. The technology, originating from research at Tokyo University of Agriculture and Technology, targets medical and healthcare applications (including a next-generation diagnostic device that visualizes and quantifies collagen fiber orientation and accumulation) and advanced non-destructive testing in industry.

1 investor

1 investor

āshibio is a biotech company developing novel therapies for rare bone and connective tissue disorders, led by a team of scientists, physicians and drug developers. Its lead product is the antibody andecaliximab.

1 investor

Ashish Life Science Pvt Limited manufactures veterinary and animal health pharmaceutical products, serving customers worldwide. Part of the Ashish Group of Industries, it operates a GMP-compliant manufacturing facility for its animal health product range.

1 investor

Asima Health is developing a non-invasive, multi-cancer blood test that uses a pan-genomic platform to detect multiple cancers from a single blood draw. The portable technology is intended for use through local diagnostic labs as part of routine blood work to identify people at risk who may need further screening.

1 investor

Asius Technologies develops ADEL® (Ambrose Diaphonic Ear Lens), a patented "second eardrum" technology for professional in-ear monitors and earbuds that absorbs in-ear pneumatic pressure to reduce the risk of hearing damage while delivering higher-fidelity sound. The company also publishes research on AI, quantum computing, and epistemology.

1 investor

Laurel provides recommendations and guidance on air purifiers, focusing on HEPA and activated carbon filter technologies for reducing indoor air pollutants including particulates, volatile organic compounds, and harmful chemicals. The service targets consumers concerned with indoor air quality and health outcomes.

1 investor

AskAt is a pharmaceutical company focused on developing new drugs with novel mechanisms for conditions that lack effective treatments, such as cancer, dementia, and autoimmune diseases. It aims to bring these therapies to patients worldwide.

1 investor

AskVERAai provides AI-powered veterinary consultations and customer engagement automation for veterinary practices. The platform uses veterinary knowledge bases and AI-generated content to deliver around-the-clock consultations, reduce response times, and enable personalized marketing communications.

1 investor

SleepHub is a platform that integrates with bedroom IoT devices to automatically optimize lighting, temperature, and humidity based on sleep state using proprietary sleep algorithms, and provides guided relaxation therapy content to address sleep anxiety and mental factors affecting sleep.

1 investor

Decedario is a board game for language and cognitive stimulation aimed at children and adults, used by therapists, educators, and families in clinical and educational settings. It supports work with conditions such as autism, ADHD, language disorders, dyslexia, Down syndrome, acquired brain injury, and dementia, and includes a platform of video-guided activities.

1 investor

Aspen Biosciences provides consulting, advisory, and research resources focused on drug discovery and biopharmaceutical R&D, serving pharmaceutical and biotech companies navigating program management, digital transformation, and emerging technologies like AI.

1 investor

AspiAir is a clinical-stage biotech company developing LASAG Inhale, an inhaled non-opioid treatment for pain and migraine attacks using acetylsalicylic acid. The company serves patients in the EU who lack access to adequate migraine medications and aims to provide a safe, mobile alternative to current therapies.

1 investor

AviadoBio is a biotech company focused on frontotemporal dementia (FTD), a form of early-onset dementia. The company engages with patients, families, and caregivers affected by FTD to develop treatment solutions.

1 investor

Aspire Pharma is a UK-based pharmaceutical company, founded in 2009, that develops and markets niche generic and branded medicines across therapy areas including urology, CNS, respiratory, ophthalmology and dermatology. It is expanding across Europe, with entities in Ireland and Germany, and grows through acquisitions and licensing deals.

1 investor